Radiation Therapy Global Market – Forecast To 2024
Radiation is one of the most common treatments for cancer and may be delivered by a machine outside the body (external-beam radiation therapy), or it may be delivered by a radioactive material placed in the body near cancer cells (internal radiation therapy/ brachytherapy), or by systemic radiation therapy which uses radioactive substances, such as radioactive iodine, that travel in the blood to kill cancer cells. About half of all cancer patients receive some type of radiation therapy sometime during the course of their treatment. Radiation therapy is sometimes given with curative intent. In such cases, radiation therapy may be used alone or in combination with surgery, chemotherapy, or both. It may also be given with palliative intent, which is not intended to cure; instead they relieve symptoms and reduce the suffering caused by cancer. For example, radiation given to the brain to shrink tumours formed from cancer cells that have spread to the brain from another part of the body. Radiation therapy kills cancer cells either by damaging DNA directly or creates charged particles (free radicals) within the cells that can in turn damage the DNA, but does not travel throughout the body as chemotherapy treatment does. But, it can cause side effects, damaging healthy cells and tissues surrounding the tumour cells, in turn can also damage the surrounding organs and it may also leads to develop a secondary cancer as a result of exposure to radiation. Today, major advances in radiation technology have made it more precise, leading to fewer side effects with the modern ways of giving radiation therapy and careful treatment planning aim to reduce the risk of these complications. The radiation therapy global market is expected to grow at mid single digit CAGR to reach 8,680.6 million by 2024.
The radiation therapy market is segmented based on their products, technology, end-users and geography. The radiation therapy market by products is segmented into external radiation therapy products, internal radiation therapy products and systemic radiation therapy products. The external radiation therapy products are further segmented into Linear accelerators (Linacs) and proton therapy systems. The internal radiation therapy product is further segmented into seeds, applicators & afterloaders, others (electronic brachytherapy & accessories) and systemic radiation therapy products are further segmented into alpha emitters and beta emitters. Based on technologies, the radiation therapy market is segmented into external radiation therapy technologies, internal radiation therapies and systemic radiation therapy technologies. External radiation therapy technologies are further segmented into Stereotactic radio surgery (SRS), Stereotactic body radiation therapy (SBRT), Image-guided radiation therapy (IGRT), Intensity-modulated radiation therapy (IMRT); Volumetric modulated arc therapy (VMAT), Intensity-modulated proton therapy (IMPT) and others. Internal radiation therapy technology is further segmented into High dose rate brachytherapy, low dose rate brachytherapy and others. Based on applications, radiation therapy market is segmented into prostate cancer, breast cancer, gynaecological cancer, gastrointestinal cancer, lung cancer, brain cancer, head & neck cancer and others. Based on end-users, radiation therapy market is segmented into hospitals, radiation therapy centres, ambulatory surgical centres and others. Further the radiation therapy global market is separated by geographical regions into North America, Europe, Asia-pacific and Rest of the World. North America is further segmented into U.S. and Others. Europe is further segmented into Germany, Italy, France, and others. Asia-pacific region is further segmented into China, Japan, India and others and Rest of the world is further segmented into Brazil, Rest of Latin America and Middle East & Others.
The radiation therapy market is segmented based on their products, technology, end-users and geography. The radiation therapy market by products is segmented into external radiation therapy products, internal radiation therapy products and systemic radiation therapy products. The external radiation therapy products are further segmented into Linear accelerators (Linacs) and proton therapy systems. The internal radiation therapy product is further segmented into seeds, applicators & afterloaders, others (electronic brachytherapy & accessories) and systemic radiation therapy products are further segmented into alpha emitters and beta emitters. Based on technologies, the radiation therapy market is segmented into external radiation therapy technologies, internal radiation therapies and systemic radiation therapy technologies. External radiation therapy technologies are further segmented into Stereotactic radio surgery (SRS), Stereotactic body radiation therapy (SBRT), Image-guided radiation therapy (IGRT), Intensity-modulated radiation therapy (IMRT); Volumetric modulated arc therapy (VMAT), Intensity-modulated proton therapy (IMPT) and others. Internal radiation therapy technology is further segmented into High dose rate brachytherapy, low dose rate brachytherapy and others. Based on applications, radiation therapy market is segmented into prostate cancer, breast cancer, gynaecological cancer, gastrointestinal cancer, lung cancer, brain cancer, head & neck cancer and others. Based on end-users, radiation therapy market is segmented into hospitals, radiation therapy centres, ambulatory surgical centres and others. Further the radiation therapy global market is separated by geographical regions into North America, Europe, Asia-pacific and Rest of the World. North America is further segmented into U.S. and Others. Europe is further segmented into Germany, Italy, France, and others. Asia-pacific region is further segmented into China, Japan, India and others and Rest of the world is further segmented into Brazil, Rest of Latin America and Middle East & Others.
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.4 MARKET DYNAMICS
3.4.1 DRIVERS AND OPPORTUNITIES
3.4.1.1 Growing prevalence of cancer cases
3.4.1.2 Adoption of unhealthy lifestyle
3.4.1.3 Technological advancements
3.4.1.4 Rising preference for non-invasive procedures of cancer treatment
3.4.1.5 Rapid rise in geriatric population
3.4.2 RESTRAINTS AND THREATS
3.4.2.1 Side effects associated with the radiation therapy
3.4.2.2 Lack of sufficient infrastructure and skilled technicians in low and middle income countries
3.4.2.3 Lack of awareness and understanding about radiation therapy’s importance
3.4.2.4 High cost of radiation therapy devices
3.4.2.5 Stringent regulatory requirements
3.5 REGULATORY AFFAIRS
3.5.1 U.S.
3.5.2 EUROPE
3.5.3 CHINA
3.5.4 INDIA
3.5.5 JAPAN
3.6 REIMBURSEMENT SCENARIO
3.6.1 REIMBURSEMENT TABLE
3.7 CLINICAL TRIAL DATA
3.8 PATENT TRENDS
3.9 TECHNOLOGICAL ADVANCEMENTS
3.9.1 INTRODUCTION
3.9.1.1 Advancements in linear accelerator technology
3.9.1.2 MRI-guided radiation therapy
3.9.1.3 Proton therapy
3.10 FUNDING SCENARIO
3.11 PORTER’S FIVE FORCE ANALYSIS
3.11.1 THREAT OF NEW ENTRANTS
3.11.2 THREAT OF SUBSTITUTES
3.11.3 BARGAINING POWER OF SUPPLIERS
3.11.4 BARGAINING POWER OF BUYERS
3.11.5 RIVALRY AMONG EXISTING COMPETITORS
3.12 SUPPLY CHAIN ANALYSIS
3.13 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.13.1 MARKET SHARE ANALYSIS OF LINAC BY MAJOR PLAYERS
3.13.2 LINAC INSTALLED BASE GLOBAL MARKET SHARE, BY REGION
3.13.3 MARKET SHARE ANALYSIS OF PROTON THERAPY SYSTEMS BY MAJOR PLAYERS
3.13.4 MARKET SHARE ANALYSIS OF BRACHYTHERAPY BY MAJOR PLAYERS
3.13.5 BRACHYTHERAPY INSTALLED BASE GLOBAL MARKET SHARE, BY
REGION
3.13.6 MARKET SHARE ANALYSIS OF ELECTRONIC BRACHYTHERAPY, BY
MAJOR PLAYERS
4 RADIATION THERAPY GLOBAL MARKET, BY PRODUCT TYPE
4.1 INTRODUCTION
4.2 EXTERNAL BEAM RADIATION THERAPY
4.2.1 LINEAR ACCELERATORS (LINACS)
4.2.2 PROTON THERAPY SYSTEMS
4.3 INTERNAL RADIATION THERAPY
4.3.1 SEEDS
4.3.2 APPLICATORS & AFTERLOADERS
4.3.3 OTHERS (ELECTRONIC BRACHYTHERAPY & ACCESSORIES)
4.4 SYSTEMIC RADIATION THERAPY
4.4.1 ALPHA EMITTERS
4.4.2 BETA EMITTERS
5 RADIATION THERAPY GLOBAL MARKET, BY TECHNOLOGY
5.1 INTRODUCTION
5.2 EXTERNAL RADIATION THERAPY
5.2.1 IMAGE-GUIDED RADIATION THERAPY (IGRT)
5.2.2 INTENSITY-MODULATED RADIATION THERAPY (IMRT)
5.2.3 VOLUMETRIC MODULATED ARC THERAPY (VMAT)
5.2.4 STEREOTACTIC BODY RADIATION THERAPY (SBRT)
5.2.5 STEREOTACTIC RADIOSURGERY (SRS)
5.2.6 INTENSITY MODULATED PROTON THERAPY (IMPT)
5.2.7 OTHER EXTERNAL RADIATION THERAPIES
5.3 INTERNAL RADIATION THERAPY
5.3.1 HIGH DOSE RATE (HDR) BRACHYTHERAPY
5.3.2 LOW DOSE RATE (LDR) BRACHYTHERAPY
5.3.3 OTHER INTERNAL RADIATION THERAPIES
5.4 SYSTEMIC RADIATION THERAPY
6 RADIATION THERAPY GLOBAL MARKET BY APPLICATIONS
6.1 INTRODUCTION
6.1.1 PROSTATE CANCER
6.1.2 GYNAECOLOGY CANCERS
6.1.3 BREAST CANCER
6.1.4 HEAD & NECK CANCER
6.1.5 LUNG CANCER
6.1.6 BRAIN CANCER
6.1.7 GASTROINTESTINAL CANCER
6.1.8 OTHERS
7 RADIATION THERAPY GLOBAL MARKET, BY END-USERS
7.1 INTRODUCTION
7.2 HOSPITALS
7.3 AMBULATORY SURGICAL CENTRES
7.4 RADIATION THERAPY SPECIALITY CENTRES
7.5 OTHERS
8 REGIONAL ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 U.S.
8.2.2 OTHERS
8.3 EUROPE
8.3.1 GERMANY
8.3.2 ITALY
8.3.3 FRANCE
8.3.4 OTHERS
8.4 ASIA PACIFIC (APAC)
8.4.1 CHINA
8.4.2 JAPAN
8.4.3 INDIA
8.4.4 OTHERS
8.5 REST OF THE WORLD (ROW)
8.5.1 BRAZIL
8.5.2 REST OF LATIN AMERICA
8.5.3 MIDDLE EAST AND OTHERS
9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 AGREEMENTS, PARTNERSHIPS AND COLLABORATIONS
9.3 APPROVALS
9.4 NEW PRODUCT LAUNCH
9.5 ACQUISITIONS
9.6 OTHER DEVELOPMENTS
10 MAJOR COMPANIES
10.1 ACCURAY, INCORPORATED
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS
10.2 BAYER AG
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORTFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS
10.3 BRAINLAB AG
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS
10.4 C.R.BARD INC.
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS
10.5 CARL ZEISS MEDITEC AG
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS
10.6 ECKERT & ZIEGLER BIBEG
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCT PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUSINESS STRATEGY
10.6.6 SWOT ANALYSIS
10.7 ELEKTA AB
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS
10.8 HITACHI MEDICAL CORPORATION
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS
10.9 IBA (ION BEAM APPLICATIONS S.A.)
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS
10.10 MEVION MEDICAL SYSYTEMS.
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS
10.11 RAYSEARCH LABORATORIES INC.,
10.11.1 OVERVIEW
10.11.2 FINANCIALS
10.11.3 PRODUCT PORTFOLIO
10.11.4 KEY DEVELOPMENTS
10.11.5 BUSINESS STRATEGY
10.11.6 SWOT ANALYSIS
10.12 VARIAN MEDICAL SYSTEMS, INC.
10.12.1 OVERVIEW
10.12.2 FINANCIALS
10.12.3 PRODUCT PORTFOLIO
10.12.4 KEY DEVELOPMENTS
10.12.5 BUSINESS STRATEGY
10.12.6 SWOT ANALYSIS
10.13 VIEWRAY, INC.,
10.13.1 OVERVIEW
10.13.2 FINANCIALS
10.13.3 PRODUCT PORTFOLIO
10.13.4 KEY DEVELOPMENTS
10.13.5 BUSINESS STRATEGY
10.13.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.4 MARKET DYNAMICS
3.4.1 DRIVERS AND OPPORTUNITIES
3.4.1.1 Growing prevalence of cancer cases
3.4.1.2 Adoption of unhealthy lifestyle
3.4.1.3 Technological advancements
3.4.1.4 Rising preference for non-invasive procedures of cancer treatment
3.4.1.5 Rapid rise in geriatric population
3.4.2 RESTRAINTS AND THREATS
3.4.2.1 Side effects associated with the radiation therapy
3.4.2.2 Lack of sufficient infrastructure and skilled technicians in low and middle income countries
3.4.2.3 Lack of awareness and understanding about radiation therapy’s importance
3.4.2.4 High cost of radiation therapy devices
3.4.2.5 Stringent regulatory requirements
3.5 REGULATORY AFFAIRS
3.5.1 U.S.
3.5.2 EUROPE
3.5.3 CHINA
3.5.4 INDIA
3.5.5 JAPAN
3.6 REIMBURSEMENT SCENARIO
3.6.1 REIMBURSEMENT TABLE
3.7 CLINICAL TRIAL DATA
3.8 PATENT TRENDS
3.9 TECHNOLOGICAL ADVANCEMENTS
3.9.1 INTRODUCTION
3.9.1.1 Advancements in linear accelerator technology
3.9.1.2 MRI-guided radiation therapy
3.9.1.3 Proton therapy
3.10 FUNDING SCENARIO
3.11 PORTER’S FIVE FORCE ANALYSIS
3.11.1 THREAT OF NEW ENTRANTS
3.11.2 THREAT OF SUBSTITUTES
3.11.3 BARGAINING POWER OF SUPPLIERS
3.11.4 BARGAINING POWER OF BUYERS
3.11.5 RIVALRY AMONG EXISTING COMPETITORS
3.12 SUPPLY CHAIN ANALYSIS
3.13 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.13.1 MARKET SHARE ANALYSIS OF LINAC BY MAJOR PLAYERS
3.13.2 LINAC INSTALLED BASE GLOBAL MARKET SHARE, BY REGION
3.13.3 MARKET SHARE ANALYSIS OF PROTON THERAPY SYSTEMS BY MAJOR PLAYERS
3.13.4 MARKET SHARE ANALYSIS OF BRACHYTHERAPY BY MAJOR PLAYERS
3.13.5 BRACHYTHERAPY INSTALLED BASE GLOBAL MARKET SHARE, BY
REGION
3.13.6 MARKET SHARE ANALYSIS OF ELECTRONIC BRACHYTHERAPY, BY
MAJOR PLAYERS
4 RADIATION THERAPY GLOBAL MARKET, BY PRODUCT TYPE
4.1 INTRODUCTION
4.2 EXTERNAL BEAM RADIATION THERAPY
4.2.1 LINEAR ACCELERATORS (LINACS)
4.2.2 PROTON THERAPY SYSTEMS
4.3 INTERNAL RADIATION THERAPY
4.3.1 SEEDS
4.3.2 APPLICATORS & AFTERLOADERS
4.3.3 OTHERS (ELECTRONIC BRACHYTHERAPY & ACCESSORIES)
4.4 SYSTEMIC RADIATION THERAPY
4.4.1 ALPHA EMITTERS
4.4.2 BETA EMITTERS
5 RADIATION THERAPY GLOBAL MARKET, BY TECHNOLOGY
5.1 INTRODUCTION
5.2 EXTERNAL RADIATION THERAPY
5.2.1 IMAGE-GUIDED RADIATION THERAPY (IGRT)
5.2.2 INTENSITY-MODULATED RADIATION THERAPY (IMRT)
5.2.3 VOLUMETRIC MODULATED ARC THERAPY (VMAT)
5.2.4 STEREOTACTIC BODY RADIATION THERAPY (SBRT)
5.2.5 STEREOTACTIC RADIOSURGERY (SRS)
5.2.6 INTENSITY MODULATED PROTON THERAPY (IMPT)
5.2.7 OTHER EXTERNAL RADIATION THERAPIES
5.3 INTERNAL RADIATION THERAPY
5.3.1 HIGH DOSE RATE (HDR) BRACHYTHERAPY
5.3.2 LOW DOSE RATE (LDR) BRACHYTHERAPY
5.3.3 OTHER INTERNAL RADIATION THERAPIES
5.4 SYSTEMIC RADIATION THERAPY
6 RADIATION THERAPY GLOBAL MARKET BY APPLICATIONS
6.1 INTRODUCTION
6.1.1 PROSTATE CANCER
6.1.2 GYNAECOLOGY CANCERS
6.1.3 BREAST CANCER
6.1.4 HEAD & NECK CANCER
6.1.5 LUNG CANCER
6.1.6 BRAIN CANCER
6.1.7 GASTROINTESTINAL CANCER
6.1.8 OTHERS
7 RADIATION THERAPY GLOBAL MARKET, BY END-USERS
7.1 INTRODUCTION
7.2 HOSPITALS
7.3 AMBULATORY SURGICAL CENTRES
7.4 RADIATION THERAPY SPECIALITY CENTRES
7.5 OTHERS
8 REGIONAL ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 U.S.
8.2.2 OTHERS
8.3 EUROPE
8.3.1 GERMANY
8.3.2 ITALY
8.3.3 FRANCE
8.3.4 OTHERS
8.4 ASIA PACIFIC (APAC)
8.4.1 CHINA
8.4.2 JAPAN
8.4.3 INDIA
8.4.4 OTHERS
8.5 REST OF THE WORLD (ROW)
8.5.1 BRAZIL
8.5.2 REST OF LATIN AMERICA
8.5.3 MIDDLE EAST AND OTHERS
9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 AGREEMENTS, PARTNERSHIPS AND COLLABORATIONS
9.3 APPROVALS
9.4 NEW PRODUCT LAUNCH
9.5 ACQUISITIONS
9.6 OTHER DEVELOPMENTS
10 MAJOR COMPANIES
10.1 ACCURAY, INCORPORATED
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS
10.2 BAYER AG
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORTFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS
10.3 BRAINLAB AG
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS
10.4 C.R.BARD INC.
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS
10.5 CARL ZEISS MEDITEC AG
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS
10.6 ECKERT & ZIEGLER BIBEG
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCT PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUSINESS STRATEGY
10.6.6 SWOT ANALYSIS
10.7 ELEKTA AB
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS
10.8 HITACHI MEDICAL CORPORATION
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS
10.9 IBA (ION BEAM APPLICATIONS S.A.)
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS
10.10 MEVION MEDICAL SYSYTEMS.
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS
10.11 RAYSEARCH LABORATORIES INC.,
10.11.1 OVERVIEW
10.11.2 FINANCIALS
10.11.3 PRODUCT PORTFOLIO
10.11.4 KEY DEVELOPMENTS
10.11.5 BUSINESS STRATEGY
10.11.6 SWOT ANALYSIS
10.12 VARIAN MEDICAL SYSTEMS, INC.
10.12.1 OVERVIEW
10.12.2 FINANCIALS
10.12.3 PRODUCT PORTFOLIO
10.12.4 KEY DEVELOPMENTS
10.12.5 BUSINESS STRATEGY
10.12.6 SWOT ANALYSIS
10.13 VIEWRAY, INC.,
10.13.1 OVERVIEW
10.13.2 FINANCIALS
10.13.3 PRODUCT PORTFOLIO
10.13.4 KEY DEVELOPMENTS
10.13.5 BUSINESS STRATEGY
10.13.6 SWOT ANALYSIS
LIST OF TABLES
Table 1 RADIATION THERAPY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
Table 2 RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS (2016-2024) ($MN)
Table 3 EXTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 4 EXTERNAL RADIATION THERAPY PRODUCTS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 5 LINEAR ACCELERATORS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 6 LINEAR ACCELERATORS NO. OF UNITS, BY REGION (2016-2024)
Table 7 PROTON THERAPY SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 8 INTERNAL RADIATION THERAPY PRODUCTS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 9 INTERNAL RADIATION THERAPY PRODUCTS GLOBAL MARKET REVENUE, BY TYPE (2016-2024) ($MN)
Table 10 SEEDS GLOBAL MARKET REVENUE,BY REGION (2016-2024) ($MN)
Table 11 APPLICATORS, & AFTERLOADERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 12 OTHER (ELECTRONIC BRACHYTHERAPY & ACCESSORIES) PRODUCTS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 13 SYSTEMIC RADIATION THERAPY PRODUCTS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 14 SYSTEMIC RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 15 ALPHA EMITTERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 16 BETA EMITTERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 17 RADIATION THERAPY GLOBAL MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
Table 18 EXTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 19 EXTERNAL RADIATION THERAPY TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 20 IGRT TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 21 IMRT TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 22 VMAT TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 23 SBRT TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 24 SRS TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 25 IMPT TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 26 OTHER EXTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 27 INTERNAL RADIATION THERAPY TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 28 INTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 29 HDR TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 30 LDR TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 31 OTHER INTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 32 SYSTEMIC RADIATION THERAPY TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 33 RADIATION THERAPY GLOBAL MARKET REVENUE, BY APPLICATIONS (2016-2024) ($MN)
Table 34 PROSTATE CANCER GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 35 GYNAECOLOGY CANCERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 36 BREAST CANCER GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 37 HEAD & NECK CANCER GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 38 LUNG CANCER GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 39 BRAIN CANCER GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 40 GASTROINTESTINAL CANCERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 41 OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 42 RADIATION THERAPY GLOBAL MARKET REVENUE, BY END-USERS (2016-2024) ($MN)
Table 43 RADIATION THERAPY HOSPITALS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 44 RADIATION THERAPY AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 45 RADAIATION THERAPY SPECIALITY CENTERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 46 RADIATION THERAPY OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 47 RADIATION THERAPY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 48 NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
Table 49 NORTH AMERICA EXTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 50 NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY PRODUCTS (2016-2024) ($MN)
Table 51 NORTH AMERICA INTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 52 NORTH AMERICA EXTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 53 NORTH AMERICA INTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 54 NORTH AMERICA SYSTEMIC RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 55 NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY APPLICATIONS (2016-2024) ($MN)
Table 56 NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY END-USERS (2016-2024) ($MN)
Table 57 NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY COUNTRY (2016-2024) ($MN)
Table 58 EUROPE RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
Table 59 EUROPE EXTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 60 EUROPE INTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 61 EUROPE RADIATION THERAPY MARKET REVENUE, BY PRODUCTS (2016-2024) ($MN)
Table 62 EUROPE EXTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 63 EUROPE INTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 64 EUROPE SYSTEMIC RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 65 EUROPE RADIATION THERAPY MARKET REVENUE, BY APPLICATIONS (2016-2024) ($MN)
Table 66 EUROPE RADIATION THERAPY MARKET REVENUE, BY END-USERS (2016-2024) ($MN)
Table 67 EUROPE RADIATION THERAPY MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
Table 68 APAC RADIATION THERAPY MARKET REVENUE, BY PRODUCTS (2016-2024) ($MN)
Table 69 APAC EXTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 70 APAC INTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 71 APAC SYSTEMIC RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 72 APAC RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
Table 73 APAC EXTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 74 APAC INTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 75 APAC RADIATION THERAPY MARKET REVENUE, BY APPLICATIONS (2016-2024) ($MN)
Table 76 APAC RADIATION THERAPY MARKET REVENUE, BY END-USERS (2016-2024) ($MN)
Table 77 APAC RADIATION THERAPY MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
Table 78 ROW RADIATION THERAPY MARKET REVENUE, BY PRODUCTS (2016-2024) ($MN)
Table 79 ROW EXTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 80 ROW INTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 81 ROW SYSTEMIC RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 82 ROW RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
Table 83 ROW EXTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 84 ROW INTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 85 ROW RADIATION THERAPY MARKET REVENUE, BY APPLICATIONS (2016-2024) ($MN)
Table 86 ROW RADIATION THERAPY MARKET REVENUE, BY END-USERS (2016-2024) ($MN)
Table 87 ROW RADIATION THERAPY MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
Table 88 AGREEMENTS, PARTNERSHIPS & COLLABORATIONS, (2016-2017)
Table 89 APPROVALS, (2016-2017)
Table 90 NEW PRODUCT LAUNCH, (2016-2017)
Table 91 ACQUISITIONS, (2016-2017)
Table 92 OTHER DEVELOPMENTS (2016-2017)
Table 93 ACCURAY, INC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
Table 94 ACCURAY, INC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
Table 95 ACCURAY, INC: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
Table 96 BAYER AG: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
Table 97 BAYER AG: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
Table 98 BAYER AG: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
Table 99 C.R.BARD INC.: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
Table 100 C.R.BARD INC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
Table 101 CARL ZEISS MEDITEC AG: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
Table 102 CARL ZEISS MEDITEC AG: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
Table 103 CARL ZEISS MEDITEC AG: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
Table 104 ECKERT & ZIEGLER GROUP: TOTAL REVENUE AND R&D EXPENSES, (2015 - 2017) ($MN)
Table 105 ECKERT & ZIEGLER GROUP: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
Table 106 ELEKTA AB: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
Table 107 ELEKTA AB: TOTAL REVENUE, BY SEGMENTS (2015-2017) ($MN)
Table 108 ELEKTA AB: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
Table 109 HITACHI MEDICAL CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
Table 110 HITACHI MEDICAL CORPORATION: TOTAL REVENUE, BY SEGMENTS (2015-2017) ($MN)
Table 111 HITACHI MEDICAL CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
Table 112 IBA: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 113 IBA: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 114 IBA: TOTAL REVENUE, BY PROTON THERAPY SEGMENT, (2014-2016) ($MN)
Table 115 IBA: TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($MN)
Table 116 RAYSEARCH LABORATORIES INC.: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
Table 117 RAYSERACH LABORATORIES: TOTAL REVENUE, BY SEGMENTS (2015-2017) ($MN)
Table 118 RAYSEARCH LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
Table 119 VARIAN MEDICAL SYSTEMS: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
Table 120 VARIAN MEDICAL SYSTEMS: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
Table 121 VARIAN MEDICAL SYSTEMS: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
Table 1 RADIATION THERAPY GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
Table 2 RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS (2016-2024) ($MN)
Table 3 EXTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 4 EXTERNAL RADIATION THERAPY PRODUCTS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 5 LINEAR ACCELERATORS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 6 LINEAR ACCELERATORS NO. OF UNITS, BY REGION (2016-2024)
Table 7 PROTON THERAPY SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 8 INTERNAL RADIATION THERAPY PRODUCTS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 9 INTERNAL RADIATION THERAPY PRODUCTS GLOBAL MARKET REVENUE, BY TYPE (2016-2024) ($MN)
Table 10 SEEDS GLOBAL MARKET REVENUE,BY REGION (2016-2024) ($MN)
Table 11 APPLICATORS, & AFTERLOADERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 12 OTHER (ELECTRONIC BRACHYTHERAPY & ACCESSORIES) PRODUCTS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 13 SYSTEMIC RADIATION THERAPY PRODUCTS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 14 SYSTEMIC RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 15 ALPHA EMITTERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 16 BETA EMITTERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 17 RADIATION THERAPY GLOBAL MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
Table 18 EXTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 19 EXTERNAL RADIATION THERAPY TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 20 IGRT TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 21 IMRT TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 22 VMAT TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 23 SBRT TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 24 SRS TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 25 IMPT TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 26 OTHER EXTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 27 INTERNAL RADIATION THERAPY TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 28 INTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 29 HDR TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 30 LDR TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 31 OTHER INTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 32 SYSTEMIC RADIATION THERAPY TECHNOLOGY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 33 RADIATION THERAPY GLOBAL MARKET REVENUE, BY APPLICATIONS (2016-2024) ($MN)
Table 34 PROSTATE CANCER GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 35 GYNAECOLOGY CANCERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 36 BREAST CANCER GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 37 HEAD & NECK CANCER GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 38 LUNG CANCER GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 39 BRAIN CANCER GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 40 GASTROINTESTINAL CANCERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 41 OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 42 RADIATION THERAPY GLOBAL MARKET REVENUE, BY END-USERS (2016-2024) ($MN)
Table 43 RADIATION THERAPY HOSPITALS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 44 RADIATION THERAPY AMBULATORY SURGICAL CENTERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 45 RADAIATION THERAPY SPECIALITY CENTERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 46 RADIATION THERAPY OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 47 RADIATION THERAPY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Table 48 NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
Table 49 NORTH AMERICA EXTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 50 NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY PRODUCTS (2016-2024) ($MN)
Table 51 NORTH AMERICA INTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 52 NORTH AMERICA EXTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 53 NORTH AMERICA INTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 54 NORTH AMERICA SYSTEMIC RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 55 NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY APPLICATIONS (2016-2024) ($MN)
Table 56 NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY END-USERS (2016-2024) ($MN)
Table 57 NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY COUNTRY (2016-2024) ($MN)
Table 58 EUROPE RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
Table 59 EUROPE EXTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 60 EUROPE INTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 61 EUROPE RADIATION THERAPY MARKET REVENUE, BY PRODUCTS (2016-2024) ($MN)
Table 62 EUROPE EXTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 63 EUROPE INTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 64 EUROPE SYSTEMIC RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 65 EUROPE RADIATION THERAPY MARKET REVENUE, BY APPLICATIONS (2016-2024) ($MN)
Table 66 EUROPE RADIATION THERAPY MARKET REVENUE, BY END-USERS (2016-2024) ($MN)
Table 67 EUROPE RADIATION THERAPY MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
Table 68 APAC RADIATION THERAPY MARKET REVENUE, BY PRODUCTS (2016-2024) ($MN)
Table 69 APAC EXTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 70 APAC INTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 71 APAC SYSTEMIC RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 72 APAC RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
Table 73 APAC EXTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 74 APAC INTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 75 APAC RADIATION THERAPY MARKET REVENUE, BY APPLICATIONS (2016-2024) ($MN)
Table 76 APAC RADIATION THERAPY MARKET REVENUE, BY END-USERS (2016-2024) ($MN)
Table 77 APAC RADIATION THERAPY MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
Table 78 ROW RADIATION THERAPY MARKET REVENUE, BY PRODUCTS (2016-2024) ($MN)
Table 79 ROW EXTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 80 ROW INTERNAL RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 81 ROW SYSTEMIC RADIATION THERAPY MARKET REVENUE, BY PRODUCTS TYPE (2016-2024) ($MN)
Table 82 ROW RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
Table 83 ROW EXTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 84 ROW INTERNAL RADIATION THERAPY MARKET REVENUE, BY TECHNOLOGY TYPE (2016-2024) ($MN)
Table 85 ROW RADIATION THERAPY MARKET REVENUE, BY APPLICATIONS (2016-2024) ($MN)
Table 86 ROW RADIATION THERAPY MARKET REVENUE, BY END-USERS (2016-2024) ($MN)
Table 87 ROW RADIATION THERAPY MARKET REVENUE, BY COUNTRY, (2016-2024) ($MN)
Table 88 AGREEMENTS, PARTNERSHIPS & COLLABORATIONS, (2016-2017)
Table 89 APPROVALS, (2016-2017)
Table 90 NEW PRODUCT LAUNCH, (2016-2017)
Table 91 ACQUISITIONS, (2016-2017)
Table 92 OTHER DEVELOPMENTS (2016-2017)
Table 93 ACCURAY, INC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
Table 94 ACCURAY, INC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
Table 95 ACCURAY, INC: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
Table 96 BAYER AG: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
Table 97 BAYER AG: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
Table 98 BAYER AG: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
Table 99 C.R.BARD INC.: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
Table 100 C.R.BARD INC: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
Table 101 CARL ZEISS MEDITEC AG: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
Table 102 CARL ZEISS MEDITEC AG: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
Table 103 CARL ZEISS MEDITEC AG: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
Table 104 ECKERT & ZIEGLER GROUP: TOTAL REVENUE AND R&D EXPENSES, (2015 - 2017) ($MN)
Table 105 ECKERT & ZIEGLER GROUP: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
Table 106 ELEKTA AB: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
Table 107 ELEKTA AB: TOTAL REVENUE, BY SEGMENTS (2015-2017) ($MN)
Table 108 ELEKTA AB: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
Table 109 HITACHI MEDICAL CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
Table 110 HITACHI MEDICAL CORPORATION: TOTAL REVENUE, BY SEGMENTS (2015-2017) ($MN)
Table 111 HITACHI MEDICAL CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
Table 112 IBA: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 113 IBA: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 114 IBA: TOTAL REVENUE, BY PROTON THERAPY SEGMENT, (2014-2016) ($MN)
Table 115 IBA: TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($MN)
Table 116 RAYSEARCH LABORATORIES INC.: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
Table 117 RAYSERACH LABORATORIES: TOTAL REVENUE, BY SEGMENTS (2015-2017) ($MN)
Table 118 RAYSEARCH LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
Table 119 VARIAN MEDICAL SYSTEMS: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
Table 120 VARIAN MEDICAL SYSTEMS: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
Table 121 VARIAN MEDICAL SYSTEMS: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
LIST OF FIGURES
Figure 1 RADIATION THERAPY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Figure 2 RESEARCH METHODOLOGY: RADIATION THERAPY GLOBAL MARKET
Figure 3 RADIATION THERAPY GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 RADIATION THERAPY GLOBAL MARKET: FORECASTING MODEL
Figure 5 RADIATION THERAPY GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
Figure 6 RADIATION THERAPY GLOBAL MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 RADIATION THERAPY GLOBAL MARKET: PATENT FILING BY MAJOR PLAYERS (2012 TO 2017)
Figure 9 RADIATION THERAPY GLOBAL MARKET: PORTER’S ANALYSIS
Figure 10 RADIATION THERAPY GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
Figure 11 RADIATION THERAPY GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
Figure 12 LINAC GLOBAL MARKET SHARE ANALYSIS, BY MAJOR PLAYERS 2017 (%)
Figure 13 LINAC INSTALLED BASE GLOBAL MARKET SHARE ANALYSIS, BY REGION, 2017 (%)
Figure 14 LINACS GLOBAL INSTALL BASE OF KEY PLAYERS, BY REGION, 2017 (%)
Figure 15 PROTON THERAPY SYSTEMS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
Figure 16 BRACHYTHERAPY GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
Figure 17 BRACHYTHERPAY INSTALLED BASE GLOBAL MARKET SHARE ANALYSIS, BY REGION, 2017 (%)
Figure 18 ELECTRONIC BRACHYTHERAPY MARKET SHARE ANALYSIS, BY MAJOR PLAYERS 2017 (%)
Figure 19 RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS (2017 VS 2024) ($MN)
Figure 20 EXTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS TYPE (2017 VS 2024) ($MN)
Figure 21 INTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS TYPE (2017 VS 2024) ($MN)
Figure 22 SYSTEMIC RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS TYPE (2017 VS 2024) ($MN)
Figure 23 RADIATION THERAPY GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2017 VS 2024) ($MN)
Figure 24 EXTERNAL RADIATION THERAPY GLOBAL MARKET SHARE, BY TECHNOLOGY TYPE (2017 VS 2024) (%)
Figure 25 INTERNAL RADIATION THERAPY GLOBAL MARKET SHARE, BY TECHNOLOGY TYPE (2017 VS 2024) (%)
Figure 26 RADIATION THERAPY GLOBAL MARKET SHARE, BY APPLICATIONS (2017 VS 2024) (%)
Figure 27 RADIATION THERAPY GLOBAL MARKET REVENUE, BY END-USERS (2017 VS. 2024) ($MN)
Figure 28 RADIATION THERAPY GLOBAL MARKET REVENUE, BY REGION (2016 - 2024) ($MN), CAGR (%)
Figure 29 NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 30 NORTH AMERICA RADIATION THERAPY MARKET SHARE, BY APPLICATION (2017 VS 2024) (%)
Figure 31 U.S. RADIATION THERAPY MARKET REVENUE, Y PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 32 U.S. RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 33 OTHERS NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 34 OTHERS NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 35 EUROPE RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 36 EUROPE RADIATION THERAPY MARKET SHARE, BY APPLICATION (2017 VS 2024) (%)
Figure 37 GERMANY RADIATION THERAPY MARKET SHARE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 38 GERMANY RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 39 ITALY RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 40 ITALY RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 41 FRANCE RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 42 FRANCE RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 43 OTHER EUROPEAN COUNTRIES RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 44 OTHER EUROPEAN COUNTRIES RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 45 APAC RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 46 APAC RADIATION THERAPY MARKET SHARE, BY APPLICATION (2017 VS 2024) (%)
Figure 47 CHINA RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 48 CHINA RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 49 JAPAN RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 50 JAPAN RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 51 INDIA RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 52 INDIA RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 53 OTHER APAC COUNTRIES RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 54 OTHER APAC COUNTRIES RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 55 ROW RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 56 ROW RADIATION THERAPY MARKET SHARE, BY APPLICATION (2017 VS 2024) (%)
Figure 57 BRAZIL RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 58 BRAZIL RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 59 REST OF LATIN AMERICAN RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 60 REST OF LATIN AMERICAN RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 61 MIDDLE EAST & OTHERS RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 62 MIDDLE EAST & OTHERS RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 63 KEY GROWTH STRATEGIES, (2016-2017)
Figure 64 SWOT: ACCURAY, INC
Figure 65 SWOT: BAYER AG
Figure 66 SWOT: BRAINLAB
Figure 67 SWOT: C.R.BARD INC.
Figure 68 SWOT: CARL ZEISS MEDITEC AG
Figure 69 SWOT: ECKERT & ZIEGLER BEBIG GROUP
Figure 70 SWOT: ELEKTA
Figure 71 SWOT: HITACHI MEDICAL CORPORATION
Figure 72 SWOT: IBA (ION BEAM APPLICATIONS S.A.)
Figure 73 SWOT: MEVION MEDICAL SYSYTEMS INC.,
Figure 74 SWOT: RAYSEARCH LABORATORIES
Figure 75 SWOT: VARIAN MEDICAL SYSTEMS, INC.
Figure 76 SWOT: VIEWRAY INC.
Figure 1 RADIATION THERAPY GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
Figure 2 RESEARCH METHODOLOGY: RADIATION THERAPY GLOBAL MARKET
Figure 3 RADIATION THERAPY GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 RADIATION THERAPY GLOBAL MARKET: FORECASTING MODEL
Figure 5 RADIATION THERAPY GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
Figure 6 RADIATION THERAPY GLOBAL MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 RADIATION THERAPY GLOBAL MARKET: PATENT FILING BY MAJOR PLAYERS (2012 TO 2017)
Figure 9 RADIATION THERAPY GLOBAL MARKET: PORTER’S ANALYSIS
Figure 10 RADIATION THERAPY GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
Figure 11 RADIATION THERAPY GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
Figure 12 LINAC GLOBAL MARKET SHARE ANALYSIS, BY MAJOR PLAYERS 2017 (%)
Figure 13 LINAC INSTALLED BASE GLOBAL MARKET SHARE ANALYSIS, BY REGION, 2017 (%)
Figure 14 LINACS GLOBAL INSTALL BASE OF KEY PLAYERS, BY REGION, 2017 (%)
Figure 15 PROTON THERAPY SYSTEMS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
Figure 16 BRACHYTHERAPY GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 (%)
Figure 17 BRACHYTHERPAY INSTALLED BASE GLOBAL MARKET SHARE ANALYSIS, BY REGION, 2017 (%)
Figure 18 ELECTRONIC BRACHYTHERAPY MARKET SHARE ANALYSIS, BY MAJOR PLAYERS 2017 (%)
Figure 19 RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS (2017 VS 2024) ($MN)
Figure 20 EXTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS TYPE (2017 VS 2024) ($MN)
Figure 21 INTERNAL RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS TYPE (2017 VS 2024) ($MN)
Figure 22 SYSTEMIC RADIATION THERAPY GLOBAL MARKET REVENUE, BY PRODUCTS TYPE (2017 VS 2024) ($MN)
Figure 23 RADIATION THERAPY GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2017 VS 2024) ($MN)
Figure 24 EXTERNAL RADIATION THERAPY GLOBAL MARKET SHARE, BY TECHNOLOGY TYPE (2017 VS 2024) (%)
Figure 25 INTERNAL RADIATION THERAPY GLOBAL MARKET SHARE, BY TECHNOLOGY TYPE (2017 VS 2024) (%)
Figure 26 RADIATION THERAPY GLOBAL MARKET SHARE, BY APPLICATIONS (2017 VS 2024) (%)
Figure 27 RADIATION THERAPY GLOBAL MARKET REVENUE, BY END-USERS (2017 VS. 2024) ($MN)
Figure 28 RADIATION THERAPY GLOBAL MARKET REVENUE, BY REGION (2016 - 2024) ($MN), CAGR (%)
Figure 29 NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 30 NORTH AMERICA RADIATION THERAPY MARKET SHARE, BY APPLICATION (2017 VS 2024) (%)
Figure 31 U.S. RADIATION THERAPY MARKET REVENUE, Y PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 32 U.S. RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 33 OTHERS NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 34 OTHERS NORTH AMERICA RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 35 EUROPE RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 36 EUROPE RADIATION THERAPY MARKET SHARE, BY APPLICATION (2017 VS 2024) (%)
Figure 37 GERMANY RADIATION THERAPY MARKET SHARE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 38 GERMANY RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 39 ITALY RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 40 ITALY RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 41 FRANCE RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 42 FRANCE RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 43 OTHER EUROPEAN COUNTRIES RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 44 OTHER EUROPEAN COUNTRIES RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 45 APAC RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 46 APAC RADIATION THERAPY MARKET SHARE, BY APPLICATION (2017 VS 2024) (%)
Figure 47 CHINA RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 48 CHINA RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 49 JAPAN RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 50 JAPAN RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 51 INDIA RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 52 INDIA RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 53 OTHER APAC COUNTRIES RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 54 OTHER APAC COUNTRIES RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 55 ROW RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 56 ROW RADIATION THERAPY MARKET SHARE, BY APPLICATION (2017 VS 2024) (%)
Figure 57 BRAZIL RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 58 BRAZIL RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 59 REST OF LATIN AMERICAN RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 60 REST OF LATIN AMERICAN RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 61 MIDDLE EAST & OTHERS RADIATION THERAPY MARKET REVENUE, BY PRODUCT/END-USERS (2017 VS 2024) ($MN)
Figure 62 MIDDLE EAST & OTHERS RADIATION THERAPY MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
Figure 63 KEY GROWTH STRATEGIES, (2016-2017)
Figure 64 SWOT: ACCURAY, INC
Figure 65 SWOT: BAYER AG
Figure 66 SWOT: BRAINLAB
Figure 67 SWOT: C.R.BARD INC.
Figure 68 SWOT: CARL ZEISS MEDITEC AG
Figure 69 SWOT: ECKERT & ZIEGLER BEBIG GROUP
Figure 70 SWOT: ELEKTA
Figure 71 SWOT: HITACHI MEDICAL CORPORATION
Figure 72 SWOT: IBA (ION BEAM APPLICATIONS S.A.)
Figure 73 SWOT: MEVION MEDICAL SYSYTEMS INC.,
Figure 74 SWOT: RAYSEARCH LABORATORIES
Figure 75 SWOT: VARIAN MEDICAL SYSTEMS, INC.
Figure 76 SWOT: VIEWRAY INC.
